Ignite SD
0
Login
Register
Viewing StudyNCT01177397
Home
Search
Stocks
Certify Doc
Genes
Clinical Trials
CompTox
DrugMatrix
Open Targets
Products
Support
Bugs
eRecord
Main Search
All Studies
All Organizations
Report Bug
View Study With Definitions
Ignite Creation Date:
2024-05-05 @ 10:44 PM
Last Modification Date:
2024-10-26 @ 10:23 AM
Study NCT ID:
NCT01177397
Status:
COMPLETED
Last Update Posted:
2022-12-13
First Post:
2010-08-05
Brief Title:
Study to Assess Safety Pharmacokinetics and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors Non-Hodgkin Lymphoma or Multiple Myeloma
Sponsor:
Celgene
Organization:
Celgene
Overview
Dates
Organization
Conditions
Design
Enrollment
Locations
Outcomes
Conditions & Keywords Data
Conditions:
Name
Hormone Receptor-Positive Breast Cancer
Multiple Myeloma
Diffuse Large B-Cell Lymphoma
Glioblastoma Multiforme
Hepatocellular Carcinoma
Non-Small Cell Lung Cancer
Neuroendocrine Tumors of Non-Pancreatic Origin
Keywords:
Name
View
Multiple Myeloma
View
Advanced solid malignant neoplasmsNon-Hodgkin Lymphoma
View